课题基金 / 基金详情

Intravascular device administration sets: Replacement after Standard Versus Prolonged use (The RSVP Trial)

Intravascular device administration sets: Replacement after Standard Versus Prolonged use (The RSVP Trial)
血管内装置给药装置:标准使用后更换与长期使用(RSVP 试验)
批准号:
nhmrc : 1008428
负责人:
A/Pr E Geoffrey Playford
金额:
$107.44万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2011
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2011-01-01 至 2016-12-31

项目摘要

项目成果

A/Pr E Geoffrey Playford的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Most hospital patients need an IV drip, a small plastic tube in a vein, often the hand/arm. 14 million/yr are used in Australia. IV drips are connected to plastic tubing through which fluid & medicine is given. IV tubing is needed for a week or more, but is only used for 3-4 days as it was thought this might prevent infection. It is now thought that IV tubing can be used for a week. This would save $1 billion/year & reduce nurses workload. The research will test the safety of this approach.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
What makes sunspots become invasive cancers
  • 批准号:
    nhmrc : GNT1059012
  • 项目类别:
    Project Grants
  • 资助金额:
    $113.0万
  • 财政年份:
    2014
  • 负责人:
    A/Pr E Geoffrey Playford
  • 依托单位:
Determinants of progression of actinic keratoses to squamous cancer
  • 批准号:
    nhmrc : 1059012
  • 项目类别:
    Project Grants
  • 资助金额:
    $79.25万
  • 财政年份:
    2014
  • 负责人:
    A/Pr E Geoffrey Playford
  • 依托单位:
The SAVE Trial: Securing All intraVenous devices Effectively in hospitals. A randomised controlled trial
  • 批准号:
    nhmrc : 1041910
  • 项目类别:
    Project Grants
  • 资助金额:
    $65.37万
  • 财政年份:
    2013
  • 负责人:
    A/Pr E Geoffrey Playford
  • 依托单位:
Safety of Hendra virus anti-G glycoprotein monoclonal antibody in humans
  • 批准号:
    nhmrc : 1041833
  • 项目类别:
    NHMRC Strategic Awards
  • 资助金额:
    $26.67万
  • 财政年份:
    2012
  • 负责人:
    A/Pr E Geoffrey Playford
  • 依托单位:
海外基金